This article demonstrates experimentally that individuals making decisions about their health management are affected by the decision making environment and that law and policy can serve important roles in improving the decision environment.
Concerns about a dearth of antibiotic innovation have spurred calls for incentives to speed the development of new antibiotics. The data from this study suggest that policymakers should be focused on the clinical quality of the new drugs, not just the raw number of new drugs introduced to the market each year. In other words, quality over quantity should be the focus.
A variety of laws and legislatively enabled regulations attempt to reduce sodium in the food supply, including lowering the amount of salt in foods served in schools and child care facilities or purchased by state-regulated elder and health care facilities and prisons. Through incentives to develop grocery vendors in areas without them, at least five states provide more low sodium, high potassium fresh fruits and vegetables for our diets.
Center for Public Health Initiatives, University of Pennsylvania
Scott Burris, JD •
Center for Public Health Law Research
Alexander Wagenaar, PhD •
University of Florida
This study, published in American Journal of Preventive Medicine, details state distracted-driving policy across all 50 states and the District of Columbia. The study finds, as of 2011, 39 states and the District of Columbia had at least one form of restriction on the use of mobile communication devices in effect..
This study presents an empirical analysis of domestic violence case resolution in North Carolina from 2004 to 2010. The study finds that penalities, at least as set at the current levels, do not deter future arrests and convictions.
It finds 44 states and Washington, DC, passed youth sports TBI laws between 2009 and 2012. No state’s youth sports TBI law focuses on primary prevention. Instead, such laws focus on increasing coaches’ and parents’ ability to identify and respond to TBIs and reducing the immediate risk of multiple TBIs.
Aaron Kesselheim, MD, JD, MPH, of the Division of Pharmacoepidemiology & Pharmacoeconomics at Brigham and Women’s Hospital discusses the effects on medical innovation of statutes that provide additional intellectual property rights or related incentives to pharmaceutical, medical device, and biotechnology developers in the U.S.